Please wait...
About This Project
We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.
Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.
Browse Other Projects on Experiment
Related Projects
How does taking Ritalin affect depersonalization-derealization disorder patients?
We are investigating Ritalin's role in alleviating symptoms of depersonalization-derealization (DPDR) disorder...
A robust and clinical-friendly CRISPR diagnostic test kit for rapid SARS-COV2 detection
The high specificity and sensitivity of the CRISPR diagnostics, e.g. SHERLOCK, can detect the presence of...
Dicty World Race - finding the fastest and smartest Dicty cells
On May 16, Dicty and HL60 cells will race for the "fastest &smartest" title. Both cell types are models...